Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01727700 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette's Disorder
Tic Disorder

Interventions

DRUG: Aripiprazole
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.